PL1660055T3 - Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową - Google Patents

Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową

Info

Publication number
PL1660055T3
PL1660055T3 PL04763497T PL04763497T PL1660055T3 PL 1660055 T3 PL1660055 T3 PL 1660055T3 PL 04763497 T PL04763497 T PL 04763497T PL 04763497 T PL04763497 T PL 04763497T PL 1660055 T3 PL1660055 T3 PL 1660055T3
Authority
PL
Poland
Prior art keywords
opioid analgesic
transdermal formulation
aloe composition
aloe
composition
Prior art date
Application number
PL04763497T
Other languages
English (en)
Inventor
Elisabeth Meyer
Peter Altenschöpfer
Angelika Baumann
Sarah Mcleod
Original Assignee
Acino Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34202336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1660055(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Acino Ag filed Critical Acino Ag
Publication of PL1660055T3 publication Critical patent/PL1660055T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
PL04763497T 2003-09-02 2004-07-26 Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową PL1660055T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10340428.7A DE10340428B4 (de) 2003-09-02 2003-09-02 Opioides Analgetikum enthaltende transdermale Formulierung
EP04763497A EP1660055B1 (en) 2003-09-02 2004-07-26 Transdermal formulation comprising an opioid analgesic and an aloe composition
PCT/EP2004/008346 WO2005020966A1 (en) 2003-09-02 2004-07-26 Transdermal formulation comprising an opioid analgesic and an aloe composition

Publications (1)

Publication Number Publication Date
PL1660055T3 true PL1660055T3 (pl) 2013-03-29

Family

ID=34202336

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10012336T PL2272507T3 (pl) 2003-09-02 2004-07-26 Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową
PL04763497T PL1660055T3 (pl) 2003-09-02 2004-07-26 Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL10012336T PL2272507T3 (pl) 2003-09-02 2004-07-26 Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową

Country Status (10)

Country Link
US (1) US20070077284A1 (pl)
EP (2) EP2272507B1 (pl)
JP (2) JP5244313B2 (pl)
CA (1) CA2534338C (pl)
DE (1) DE10340428B4 (pl)
DK (2) DK2272507T3 (pl)
ES (2) ES2394313T3 (pl)
PL (2) PL2272507T3 (pl)
PT (2) PT1660055E (pl)
WO (1) WO2005020966A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007021549A1 (de) 2007-05-08 2008-11-13 Novosis Ag Transdermales therapeutisches System enthaltend mindestens zwei Opioide
DE112008002309A5 (de) * 2007-06-25 2010-05-27 Acino Ag Elektrophoretisches transdermales Applikationssystem
EP2366388A1 (de) 2010-03-17 2011-09-21 Ratiopharm GmbH Nicht-okklusives transdermales therapeutisches System zur Verabreichung von Buprenorphin
JP6359014B2 (ja) * 2013-08-21 2018-07-18 久光製薬株式会社 貼付剤
DE102014013448A1 (de) 2014-09-16 2016-03-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales Therapeutisches System umfassend Buprenorphin
US9656441B2 (en) 2015-01-08 2017-05-23 Alfred E. Tiefenbacher ( Gmbh & Co. Kg) Transdermal patch
JP6879734B2 (ja) * 2016-12-27 2021-06-02 小林製薬株式会社 皮膚浸透促進剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336243A (en) 1980-08-11 1982-06-22 G. D. Searle & Co. Transdermal nitroglycerin pad
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4751087A (en) 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4615699A (en) 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
CZ306398A3 (cs) * 1996-03-25 1999-01-13 Lts Lohmann Therapie-Systeme Gmbh Transdermální terapeutický systém s malou tloušťkou a vysokou flexibilitou a způsob jeho výroby
AU732978B2 (en) * 1996-07-10 2001-05-03 Coloplast A/S Adhesive agent and use of such agent
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
US6946144B1 (en) * 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
ATE344035T1 (de) * 1998-07-16 2006-11-15 Memorial Sloan Kettering Inst Topische zusammensetzung enthaltend ein opioid- analgetikum und einen nmda-antagonisten
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
MXPA03007885A (es) * 2001-03-02 2004-05-24 Euro Celtique Sa Norbuprenorfina n-but-3-enilo y metodos de uso.
AU2003210417B2 (en) * 2002-03-06 2007-10-11 Hexal Ag Transdermal system comprising fentanyl
ATE394097T1 (de) * 2002-03-20 2008-05-15 Euro Celtique Sa Verfahren zur verabreichung von buprenorphin zur behandlung von depression
WO2007134434A1 (en) * 2006-05-18 2007-11-29 Merck Frosst Canada Ltd. Phenanthrene derivatives as mpges-1 inhibitors

Also Published As

Publication number Publication date
EP1660055B1 (en) 2012-10-24
DK1660055T3 (da) 2012-12-17
JP2012188447A (ja) 2012-10-04
ES2394313T3 (es) 2013-01-30
EP1660055A1 (en) 2006-05-31
JP5789563B2 (ja) 2015-10-07
JP2007504183A (ja) 2007-03-01
US20070077284A1 (en) 2007-04-05
CA2534338A1 (en) 2005-03-10
CA2534338C (en) 2012-12-04
EP2272507B1 (en) 2012-10-10
DK2272507T3 (da) 2012-12-17
ES2394311T3 (es) 2013-01-30
PL2272507T3 (pl) 2013-03-29
PT1660055E (pt) 2012-12-21
JP5244313B2 (ja) 2013-07-24
EP2272507A1 (en) 2011-01-12
WO2005020966A1 (en) 2005-03-10
DE10340428B4 (de) 2015-02-12
PT2272507E (pt) 2013-01-14
DE10340428A1 (de) 2005-03-24

Similar Documents

Publication Publication Date Title
EP1613254A4 (en) TRANSDERMAL ANALGESIC COMPOSITION AND METHODS OF MAKING AND USING THE SAME
HK1192711A1 (zh) 阿片和阿片樣化合物及其用途
HK1096014A1 (en) Transdermal hormone delivery system: compositions and methods
EP1763490A4 (en) ELECTRODEIONIZATION DEVICE AND USE METHOD
HUP0303313D0 (en) Transdermal pharmaceutical compositions
EP1495026A4 (en) METHODS AND COMPOSITIONS CONTAINING NITRIC OXIDE DONORS AND OPIOID ANALGESICS
HK1087699A1 (en) Gyrase inhibitors and uses thereof
IL175260A0 (en) Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
AP2006003694A0 (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
IL157662A0 (en) N-but-3-enyl norbuprenorphine and its use as analgesic
EP1545461A4 (en) COMBINED ANALGESIC COMPOSITION WITH IMMEDIATE AND PROLONGED RELEASE
GB0404327D0 (en) Pharmaceutical composition and method of using same
PL1660055T3 (pl) Preparat przezskórny zawierający opioidowy środek przeciwbólowy i kompozycję aloesową
PT1749090T (pt) Formulação, método e composição para terapia celular
EP1583528A4 (en) NF-KB INHIBITORS AND ITS USES
EP1962589A4 (en) SYNERGISTIC COMBINATIONS OF NORKETAMINE AND OPIOID ANALGETICS
EP1407771A4 (en) SOPHORIDINE AND ITS USE AS ANALYZIC
AU2003236365A1 (en) Medicinal composition comprising acat inhibitor and insuline resistance improving agent
IL177751A0 (en) Pharmaceutical composition of (+)-erythro-mefloquine and its use
GB0622684D0 (en) Feed preparation device and method of use
AU2003246888A1 (en) Use of devazepide in combination with an opioid analgesic for potentiating the effect of the analgesic
GB0608399D0 (en) Pharmaceutical composition and method of using same
GB0321723D0 (en) New analgesic compositions and their administration
GB0301812D0 (en) Analgesic composition
GB0409779D0 (en) New analgesic compositions and their administration